Market Cap
$2.32 Billion
USD as of July 1, 2025
| Company | Market Cap (USD) |
|---|---|
Novo Nordisk
|
$309.91 B |
Vertex Pharmaceuticals Incorporated
|
$117.36 B |
CSL Limited
|
$95.75 B |
Regeneron Pharmaceuticals, Inc.
|
$59.14 B |
| Marinomed Biotech AG | $58.56 B |
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$699.59 B |
Johnson & Johnson
|
$374.29 B |
AbbVie
|
$336.94 B |
Novo Nordisk
|
$309.91 B |
UnitedHealth Group
|
$279.90 B |
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
United States
languages
Healthcare
languages
Biotechnology
United States Healthcare
United States Biotechnology
Arrowhead Pharmaceuticals, Inc. has the following listings and related stock indices.
Stock: NASDAQ: ARWR
Stock: FSX: HDP1
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.